CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | BVF PARTNERS L P/IL Director | Grant or award · Option to Buy | +6,682 | 6,682 | ||
| 2025-02-27 | Santos da Silva Jorge Chief Executive Officer | Grant or award | +95,763 | 3,078,577 | ||
| 2025-02-27 | Reich Kristian Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +139,273 | 139,273 | ||
| 2025-02-27 | Bodenstedt Matthias Chief Financial Officer | Grant or award | +95,763 | 616,666 | ||
| 2025-01-20 | Reich Kristian Chief Scientific Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −1,456 | 1,052 | ||
| 2025-01-20 | Reich Kristian Chief Scientific Officer | Conversion | +111,949 | 153,930 | ||
| 2025-01-20 | Reich Kristian Chief Scientific Officer | Returned to the company | −111,949 | 84,367 | ||
| 2025-01-20 | Reich Kristian Chief Scientific Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −3,328 | 2,508 | ||
| 2024-10-04 | Sturge Simon Director | Sale | −171,000 | $53.72 | $9.2M | 171,980 |
| 2024-10-04 | BVF PARTNERS L P/IL Director | Sale | −1,030,589 | $50.00 | $51.5M | 10,235,089 |
| 2024-10-04 | BVF PARTNERS L P/IL Director | Sale | −836,862 | $50.00 | $41.8M | 8,168,838 |
| 2024-10-04 | BVF PARTNERS L P/IL Director | Sale | −132,549 | $50.00 | $6.6M | 1,287,768 |
| 2024-06-06 | BVF PARTNERS L P/IL Director | Grant or award · Option to Buy | +7,688 | 7,688 | ||
| 2024-06-06 | Moukheibir Catherine Director | Grant or award · Option to Buy | +7,688 | 7,688 | ||
| 2024-06-06 | Phillips Andrew John Director | Grant or award · Option to Buy | +7,688 | 7,688 | ||
| 2024-06-06 | Xavier Ramnik Director | Grant or award · Option to Buy | +7,688 | 7,688 | ||
| 2024-06-06 | Sturge Simon Director | Grant or award · Option to Buy | +7,688 | 7,688 | ||
| 2024-06-06 | Loy Spike Director | Grant or award · Option to Buy | +7,688 | 7,688 | ||
| 2024-02-29 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −4,740 | $55.89 | $265K | 2,982,814 |
| 2024-02-28 | Santos da Silva Jorge Chief Executive Officer | Sale 10b5-1 | −56,065 | $55.00 | $3.1M | 2,987,554 |
Page 4 of 10 · 184 trades